Literatur
Als-Nielsen B, Gluud LL, Gluud C (2004) Nonabsorbable disaccharides for hepatic encephalopathy. Cochrane Database Syst Rev 2: CD003044
Bircher J, Müller J, Guggenheim P, Hämmerli UP (1966) Treatment of chronic portal-systemic encephalopathy with lactulose. Lancet 1 (7443): 890–892
Häussinger HE, Schliess F (2008) Pathogenetic mechanisms of hepatic encephalopathy. Gut 57: 1156–1165
Prasad S, Dhiman RK, Duseja A et al (2007) Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology 45: 549–559
Riggio O, Balducci G, Ariosto F et al (1989) Lactitol in prevention of recurrent episodes of hepatic encephalopathy in cirrhotic patients with portal-systemic shunt. Dig Dis Sci 34: 823–829
Uribe M, Campollo O, Vargas F et al (1987) Acidifying enemas (lactitol and lactose) vs. nonacidifying enemas (tap water) to treat acute portal-systemic encephalopathy: a double-blind, randomized clinical trial. Hepatology 7: 639–643
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Grünhage, F., Lammert, F. Sekundärprophylaxe der hepatischen Enzephalopathie mit oraler Laktulose. Gastroenterologe 4, 555–556 (2009). https://doi.org/10.1007/s11377-009-0361-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11377-009-0361-8